A detailed history of Eley Financial Management, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Eley Financial Management, Inc holds 20,715 shares of NVO stock, worth $2.18 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
20,715
Previous 19,804 4.6%
Holding current value
$2.18 Million
Previous $2.83 Billion 12.75%
% of portfolio
0.99%
Previous 1.2%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $108,472 - $132,477
911 Added 4.6%
20,715 $2.47 Billion
Q2 2024

Aug 09, 2024

SELL
$122.71 - $146.91 $137,680 - $164,833
-1,122 Reduced 5.36%
19,804 $2.83 Billion
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $2.14 Million - $2.84 Million
20,926 New
20,926 $2.69 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Eley Financial Management, Inc Portfolio

Follow Eley Financial Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eley Financial Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eley Financial Management, Inc with notifications on news.